DocGo (DCGO) to Release Earnings on Wednesday

DocGo (NASDAQ:DCGO) is set to release its earnings data after the market closes on Wednesday, May 8th. Analysts expect DocGo to post earnings of $0.09 per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

DocGo (NASDAQ:DCGO) last released its quarterly earnings data on Wednesday, February 28th. The company reported $0.06 EPS for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.07). DocGo had a return on equity of 2.01% and a net margin of 1.10%. The company had revenue of $199.25 million for the quarter, compared to analysts’ expectations of $195.48 million. On average, analysts expect DocGo to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

DocGo Trading Up 2.8 %

Shares of DocGo stock opened at $3.61 on Monday. The company has a 50-day moving average of $3.71 and a two-hundred day moving average of $4.46. DocGo has a 12-month low of $2.78 and a 12-month high of $10.82. The stock has a market cap of $376.05 million, a PE ratio of 51.57, a price-to-earnings-growth ratio of 0.41 and a beta of 0.96.

Analyst Ratings Changes

A number of analysts have commented on DCGO shares. Stifel Nicolaus decreased their target price on DocGo from $8.00 to $6.50 and set a “buy” rating on the stock in a research report on Tuesday, April 30th. Cantor Fitzgerald lowered their price objective on shares of DocGo from $13.00 to $11.00 and set an “overweight” rating on the stock in a research note on Thursday, February 29th. Canaccord Genuity Group cut their target price on shares of DocGo from $10.00 to $9.00 and set a “buy” rating for the company in a research report on Thursday, April 11th. BTIG Research lowered their price target on shares of DocGo from $13.00 to $11.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Finally, Needham & Company LLC cut their price objective on DocGo from $14.00 to $10.00 and set a “buy” rating for the company in a research report on Thursday, February 29th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $10.58.

Insiders Place Their Bets

In other news, Director Michael J. Burdiek acquired 10,000 shares of the business’s stock in a transaction dated Thursday, March 14th. The stock was acquired at an average price of $3.61 per share, with a total value of $36,100.00. Following the completion of the transaction, the director now directly owns 571,595 shares in the company, valued at approximately $2,063,457.95. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 13.78% of the stock is owned by corporate insiders.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.